ArticleHealth science reports2026
Investigating the Association Between Serum 25-Hydroxyvitamin D (25(OH)D) and Body Mass Index (BMI) With In Vitro Fertilization (IVF) Outcomes Among Iranian Women: A Case-Control Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Infertility affects approximately 18.3% of couples in Iran, and in vitro fertilization (IVF) remains a widely used treatment. Vitamin D deficiency and elevated body mass index (BMI) have been linked to poorer reproductive outcomes in some populations, but region-specific evidence among Iranian women is limited. This study aimed to investigate the association between serum 25-hydroxyvitamin D [25(OH)D] levels, BMI, and IVF outcomes in Iranian women. Methods: This case-control study was conducted at Fatemieh Medical Training Center, Hamadan, Iran. A total of 314 women undergoing IVF were included (157 with successful clinical pregnancy confirmed by positive β-hCG test and 157 with unsuccessful outcomes). Serum 25(OH)D levels were measured using enzyme-linked immunosorbent assay (ELISA). BMI was calculated as weight (kg)/height (m²) and categorized as normal (18.5-24.9), overweight (25-29.9), and obese (≥ 30). Exclusion criteria included systemic diseases, insulin resistance, polycystic ovary syndrome (PCOS), and diabetes. Data were collected using a researcher-developed checklist from patient records. Statistical analyses were performed using Stata version 14. Pearson correlation coefficients were used to assess associations between continuous variables, and multivariable logistic regression was applied to estimate odds ratios (ORs) with 95% confidence intervals (CIs) for IVF failure, adjusting for age. All tests were two-sided with a significance level of Results: Mean serum 25(OH)D levels were significantly lower in the unsuccessful IVF group (17.8 ± 5.9 ng/mL) compared to the successful group (24.6 ± 6.8 ng/mL; mean difference = 6.8 ng/mL, Conclusion: Vitamin D deficiency and higher BMI are independently associated with increased risk of IVF failure among Iranian women. Optimizing vitamin D status and achieving a healthy BMI prior to IVF treatment may improve success rates. Given the observed association, routine assessment and supplementation of vitamin D in women of reproductive age preparing for assisted reproductive technologies should be considered. Future studies should adjust for additional potential confounders, including chronic inflammation and lifestyle factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.